Plasma N-terminal pro-B-type natriuretic peptide concentration helps to predict survival in dogs with symptomatic degenerative mitral valve disease regardless of and in combination with the initial clinical status at admission

Simpson's Method of Discs for Measurement of Echocardiographic End‐Diastolic and End‐Systolic Left Ventricular Volumes: Breed‐Specific Reference Ranges in Boxer Dogs

“…Although SMOD is the current ASE‐recommended method for measurement of LV volumes in humans and seems to be very accurate compared with other methods in dogs, studies describing reference ranges are scarce 19, 20. Boxer dogs are particularly prone to heart disease and breed‐specific M‐mode and Doppler reference ranges have been generated for this breed 1…”

NT-ProBNP and cardiac troponin I in virulent canine babesiosis

“…In a study of 330 dogs presented with cough or dyspnea, showed that, although NT-proBNP concentrations were remarkably lower than in humans, NT-proBNP was able to discriminate between heart failure and non-heart failure as a cause for the clinical signs (even in dogs with a previous medical history of heart failure) and also correlated with severity of heart failure (De Francesco et al, 2007). In a study in dogs with mitral valve disease, NT-proBNP was shown to be an aid in the evaluation of the symptomatic phase and provided information on both disease severity and prognosis (Serres et al, 2009). …”

Assessment and Quantification of Acquired Valvular Regurgitation in Dogs

“…Close to one third of these dogs had an RF >30%. Another study conducted by the same group showed that dogs with asymptomatic DMVD and an RF >30% had greater plasma concentration of NT-proBNP and were more likely to decompensate in the following year than were dogs with an RF <30% [52]. Therefore RF is an important criterion to stratify the risk of developing CHF and the prognosis in dogs with DMVD, as established in human medicine [53,54].…”